ABSTRACT
Mebendazole is a benzimidazole carbamate anthelmintic, originally synthesized by Janssen Pharmaceutica Research Laboratories in Belgium. It was initially developed as a veterinary anthelmintic but was subsequently registered for human use. It is currently marketed as Vermox by Johnson and Johnson, although a large number of generic products whose bioequivalence seems to be variable are available, especially in developing countries.
